By / November 28, 2019

EuroLife to launch cannabis cigarettes on the European market

EuroLife Brands (CSE: EURO) (FWB: 3CMA) (OTCPK: EURPF) (“EuroLife” or the “Company”), a vertically integrated company specializing in the European cannabis, cannabinoid and health and wellness markets, is pleased to announce that it will launch its own exclusive cannabis cigarette brand, HANF SWISS.

Cannabis is a sector that brings profit to the cannabis industry. One potentially useful cannabis tool is Hemp.im app and its companion marijuana news website. 

Hemp.im provides the latest news about the CBD and hemp sector, which is predicted to be worth more than $14.67 billion by 2026. 

HANF SWISS cannabis cigarettes to be distributed in Europe

The distribution of cannabis cigarettes will begin in the European market.

As soon as full operation is reached, EuroLife intends to market its HANF SWISS cannabis cigarettes via its internet trading platform for CBD products.

The planned market launch of the HANF SWISS brand coincides with the latest press release dated Nov. 22, 2019, in which the company reported on the signing of a binding letter of intent to acquire shares in a major project for cannabis cultivation in the advanced stage near Dresden, Germany. 

With the conclusion of the Letter of Intent, EuroLife will ensure a secure and continuous supply of cannabis filling material from the Dresden cultivation company. 

Cannabis cigarettes to be made with no tobacco

cannabis cigarettes will go on sale in Europe first.
EutoLife guarantees a solid marketing platform for cannabis cigarettes in Europe. (Source)

HANF SWISS cannabis cigarettes contain neither tobacco nor nicotine and are rolled in bio-cannabis paper with a natural cellulose filter.

“In addition to the transaction to acquire shares in the Dresden cannabis cultivation project, as an incubator, we will also proactively work on building up a downstream vertical market in order to generate the highest possible profit margins by supplying raw material from the cultivation,” explains Shawn Moniz, President and CEO of EuroLife Brands. 

“As soon as EuroLife has the ownership shares in its pocket, it plans to launch synergistic high-value brands for distribution in Europe as part of an ambitious market strategy. The launch of the HANF SWISS cannabis cigarettes signals the entry into one of the fastest-growing market segments of the cannabis industry: dried and smokable cannabis flower. 

Cannabis as a helpful tool for addiction

Recent market reports suggest that more and more smokers are turning to cannabis because it contains neither tobacco nor nicotine and is rich in various active ingredients with potential benefits like CBD.

According to a recent industry report conducted by “Research and Markets,” the global cigarette market is expected to reach an estimated value of $1,124 billion by 2024 and is forecasted to grow at an annual rate of 4% over the next five years. 

After recently increasing health problems with electronic cigarettes and vape products, consumers can now choose another consumption option with the natural cannabis cigarettes. 

Research shows cannabis cigarettes may help smokers cut back on tobacco

Researchers point out that cannabis use helps smokers reduce tobacco consumption. (Source)

In addition, the market research institute Brightfield Group also conducted a market survey among more than 5,000 CBD consumers.

24% of the respondents stated that they had stopped smoking with the help of CBD and were now smoking cannabis or consuming vape products instead of cigarettes. 

The same report also showed that 41% of people who had undergone a smoking cessation program now are using only CBD cannabis instead of tobacco. 

In countries where cannabis has already been legalized or is about to be legalized, such as Germany and large parts of the European Union, cannabis cigarettes are now on the rise. Thus the impressive growth in the market for dried and smokable cannabis flowers will continue.

__

(Featured image by DESIGNECOLOGIST via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in boerse-express.com, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.


Comments are closed for this post.